Sign in
4

Changes in Ownership

Lantern Pharma Inc. Filed Acc 0001493152-25-014615

Options or other derivatives

  • Chief Scientific Officer acquired 69,600 shares (grant or award)
  • Chief Scientific Officer returned 69,600 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Bhatia Kishor G. · Chief Scientific Officer

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2020-06-15 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −52,200 0 D
2020-06-15 Grant or award : show line 2 in the form Stock Option (Right to Buy) +52,200 52,200 D
2021-10-29 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −17,400 0 D
2021-10-29 Grant or award : show line 4 in the form Stock Option (Right to Buy) +17,400 17,400 D
Loading xslF345X05/ownership.xml…